VMD vs. TRNS

Last updated Jun 4, 2026

VMD (Viemed Healthcare Inc) and TRNS (Transcat, Inc.) are both stocks. VMD operates in Medical Devices (Healthcare), while TRNS operates in Industrial Distribution (Industrials). Over the past 5 years, VMD returned 5.95%/yr vs 10.04%/yr for TRNS. At a 0.15 correlation, their price movements are largely independent.

Performance

VMD vs. TRNS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Viemed Healthcare Inc (VMD) and Transcat, Inc. (TRNS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VMD achieves a 28.67% return, which is significantly lower than TRNS's 59.00% return.

VMD

• 1D: 0.84%
• 1M: 0.84%
• YTD: 28.67%
• 6M: 41.42%
• 1Y: 40.80%
• 3Y*: -0.82%
• 5Y*: 5.95%
• 10Y*: —

TRNS

• 1D: -0.40%
• 1M: 27.82%
• YTD: 59.00%
• 6M: 63.23%
• 1Y: 4.94%
• 3Y*: 0.76%
• 5Y*: 10.04%
• 10Y*: 24.18%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VMD vs. TRNS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
VMD Viemed Healthcare Inc	28.67%	-7.36%	2.17%	3.84%	44.83%	-32.73%	25.16%	63.16%	111.86%
TRNS Transcat, Inc.	59.00%	-46.35%	-3.28%	54.27%	-23.33%	166.52%	8.85%	67.51%	40.89%

Correlation

The correlation between VMD and TRNS is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.25
Correlation (3Y) Calculated over the trailing 3-year period	0.20
Correlation (5Y) Calculated over the trailing 5-year period	0.19
Correlation (All Time) Calculated using the full available price history since Jan 5, 2018	0.15

Fundamentals

Market Cap VMD : $387.10M TRNS : $842.92M
EPS VMD : $0.37 TRNS : $0.58
PE Ratio VMD : 26.04 TRNS : 156.71
PS Ratio VMD : 1.35 TRNS : 2.54
PB Ratio VMD : 2.69 TRNS : 2.80
Total Revenue (TTM) VMD : $286.57M TRNS : $331.88M
Gross Profit (TTM) VMD : $163.52M TRNS : $108.40M
EBITDA (TTM) VMD : $46.09M TRNS : $33.66M

Return for Risk

VMD vs. TRNS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VMD

VMD Risk / Return Rank: 73
VMD Sharpe Ratio Rank: 73
VMD Sortino Ratio Rank: 67
VMD Omega Ratio Rank: 68
VMD Calmar Ratio Rank: 78
VMD Martin Ratio Rank: 78

TRNS

TRNS Risk / Return Rank: 42
TRNS Sharpe Ratio Rank: 44
TRNS Sortino Ratio Rank: 42
TRNS Omega Ratio Rank: 41
TRNS Calmar Ratio Rank: 43
TRNS Martin Ratio Rank: 43

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VMD vs. TRNS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Viemed Healthcare Inc (VMD) and Transcat, Inc. (TRNS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	VMD	TRNS	Difference
Sharpe ratio Return per unit of total volatility	1.07	0.10	+0.96
Sortino ratio Return per unit of downside risk	1.56	0.50	+1.07
Omega ratio Gain probability vs. loss probability	1.21	1.06	+0.15
Calmar ratio Return relative to maximum drawdown	2.40	0.12	+2.29
Martin ratio Return relative to average drawdown	5.94	0.22	+5.71
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

VMD vs. TRNS - Sharpe Ratio Comparison

The current VMD Sharpe Ratio is 1.07, which is higher than the TRNS Sharpe Ratio of 0.10. The chart below compares the historical Sharpe Ratios of VMD and TRNS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	VMD	TRNS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.07	0.10	+0.96
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.15	0.23	-0.09
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.57	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.17	+0.22

Drawdowns

VMD vs. TRNS - Drawdown Comparison

The maximum VMD drawdown since its inception was -69.35%, smaller than the maximum TRNS drawdown of -93.42%. Use the drawdown chart below to compare losses from any high point for VMD and TRNS.

Drawdown Indicators

	VMD	TRNS	Difference
Max Drawdown Largest peak-to-trough decline	-69.35%	-93.42%	+24.07%
Max Drawdown (1Y) Largest decline over 1 year	-17.06%	-42.92%	+25.86%
Max Drawdown (3Y) Largest decline over 3 years	-41.81%	-63.86%	+22.05%
Max Drawdown (5Y) Largest decline over 5 years	-52.71%	-63.86%	+11.15%
Max Drawdown (10Y) Largest decline over 10 years	—	-63.86%	—
Current Drawdown Current decline from peak	-18.78%	-37.39%	+18.61%
Average Drawdown Average peak-to-trough decline	-29.51%	-35.38%	+5.87%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.89%	22.35%	-15.46%

Volatility

VMD vs. TRNS - Volatility Comparison

Viemed Healthcare Inc (VMD) and Transcat, Inc. (TRNS) have volatilities of 17.58% and 18.16%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VMD	TRNS	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.58%	18.16%	-0.58%
Volatility (6M) Calculated over the trailing 6-month period	29.78%	35.36%	-5.58%
Volatility (1Y) Calculated over the trailing 1-year period	38.61%	47.62%	-9.01%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	40.98%	43.36%	-2.38%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	57.86%	42.39%	+15.47%

Dividends

VMD vs. TRNS - Dividend Comparison

Neither VMD nor TRNS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

VMD vs. TRNS - Profitability Comparison

The chart below illustrates the profitability comparison between Viemed Healthcare Inc and Transcat, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

VMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Viemed Healthcare Inc reported a gross profit of 42.83M and revenue of 75.41M. Therefore, the gross margin over that period was 56.8%.

TRNS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Transcat, Inc. reported a gross profit of 30.47M and revenue of 88.62M. Therefore, the gross margin over that period was 34.4%.

VMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Viemed Healthcare Inc reported an operating income of 4.30M and revenue of 75.41M, resulting in an operating margin of 5.7%.

TRNS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Transcat, Inc. reported an operating income of 2.73M and revenue of 88.62M, resulting in an operating margin of 3.1%.

VMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Viemed Healthcare Inc reported a net income of 2.58M and revenue of 75.41M, resulting in a net margin of 3.4%.

TRNS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Transcat, Inc. reported a net income of 744.00K and revenue of 88.62M, resulting in a net margin of 0.8%.

Frequently Asked Questions

Can I hold both VMD and TRNS in my portfolio?

VMD and TRNS have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VMD or TRNS?

TRNS has higher volatility (18.16%) compared to VMD (17.58%). In terms of maximum drawdown, VMD dropped -69.35% vs TRNS's -93.42%.

Which has better risk-adjusted returns?

VMD currently has the higher Sharpe Ratio (1.07 vs 0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.